跳转至内容
Merck
CN

A case of erythema multiforme developing after levetiracetam therapy.

Dermatology online journal (2013-03-12)
Yavuz Yesilova, Enver Turan, Abdurahman Sonmez, Ilyas Ozardali
摘要

Erythema multiforme is a skin disease, which occurs particularly in the acral region, and is characterized by target-like erythematous macules and papules. Infections play an important role in the etiology of erythema multiforme. Other causes include drugs, vaccination, and hematological malignancies. Half of all cases may not have an identifiable etiology. This article presents a male patient who developed erythema multiforme as a result of levetiracetam use for epilepsy.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
吡拉西坦
Supelco
Levetiracetam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
左乙拉西坦, European Pharmacopoeia (EP) Reference Standard
Levetiracetam impurity D, European Pharmacopoeia (EP) Reference Standard